Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2019

Ausgabe 1/2019

Inhaltsverzeichnis ( 26 Artikel )

21.01.2019 | Review | Ausgabe 1/2019

Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?

Suzanne B. Coopey, Kinyas Kartal, Clara Li, Adam Yala, Regina Barzilay, Heather R. Faulkner, Tari A. King, Francisco Acevedo, Judy E. Garber, Anthony J. Guidi, Kevin S. Hughes

22.01.2019 | Review | Ausgabe 1/2019 Open Access

The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea

Hope S. Rugo, Jack A. Di Palma, Debu Tripathy, Richard Bryce, Susan Moran, Elizabeth Olek, Linda Bosserman

01.02.2019 | Review | Ausgabe 1/2019

Tamoxifen and pregnancy: an absolute contraindication?

T. N. Schuurman, P. O. Witteveen, E. van der Wall, J. L. M. Passier, A. D. R. Huitema, F. Amant, C. A. R. Lok

22.01.2019 | Preclinical Study | Ausgabe 1/2019

The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer

Rokaya El-Ansari, Madeleine L. Craze, Lutfi Alfarsi, Daniele Soria, Maria Diez-Rodriguez, Christopher C. Nolan, Ian O. Ellis, Emad A. Rakha, Andrew R. Green

02.02.2019 | Preclinical study | Ausgabe 1/2019

S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells

Elena Strekalova, Dmitry Malin, Erin M. M. Weisenhorn, Jason D. Russell, Dominik Hoelper, Aayushi Jain, Joshua J. Coon, Peter W. Lewis, Vincent L. Cryns

02.02.2019 | Preclinical study | Ausgabe 1/2019

Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases

Zhi-Hua Liu, Kun Wang, Dan-Yi Lin, Jie Xu, Jie Chen, Xiao-Yu Long, Yan Ge, Xin-Lan Luo, Ke-Ping Zhang, Yan-Hui Liu, Fang-Ping Xu

04.02.2019 | Preclinical study | Ausgabe 1/2019

An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network

Min Sun, Di Wu, Ke Zhou, Heng Li, Xingrui Gong, Qiong Wei, Mengyu Du, Peijie Lei, Jin Zha, Hongrui Zhu, Xinsheng Gu, Dong Huang

06.02.2019 | Preclinical study | Ausgabe 1/2019

ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness

Yin Liu, Puspa R. Pandey, Sambad Sharma, Fei Xing, Kerui Wu, Amar Chittiboyina, Shih-Ying Wu, Abhishek Tyagi, Kounosuke Watabe

09.02.2019 | Preclinical study | Ausgabe 1/2019

Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer

Yujia Lan, Erjie Zhao, Shangyi Luo, Yun Xiao, Xia Li, Shujun Cheng

12.02.2019 | Preclinical study | Ausgabe 1/2019 Open Access

Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers

Constantinos Savva, Karen De Souza, Reem Ali, Emad A. Rakha, Andrew R. Green, Srinivasan Madhusudan

22.01.2019 | Clinical trial | Ausgabe 1/2019

Prognostic effects of abnormal DNA damage response protein expression in breast cancer

Koung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, Hyojin Kim, Ahrum Min, Tae-Yong Kim, Yaewon Yang, Han-Byoel Lee, Hyeong-Gon Moon, Sae-Won Han, Do-Youn Oh, Wonshik Han, In Ae Park, Dong-Young Noh, Seock-Ah Im

23.01.2019 | Clinical trial | Ausgabe 1/2019 Open Access

Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer

Nicola J. Camp, Michael J. Madsen, Jesús Herranz, Álvaro Rodríguez-Lescure, Amparo Ruiz, Miguel Martín, Philip S. Bernard

23.01.2019 | Clinical Trial | Ausgabe 1/2019

Differences between screen-detected and interval breast cancers among BRCA mutation carriers

Melissa Pilewskie, Emily C. Zabor, Elizabeth Gilbert, Michelle Stempel, Oriana Petruolo, Debra Mangino, Mark Robson, Maxine S. Jochelson

24.01.2019 | Clinical trial | Ausgabe 1/2019 Open Access

Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)—PathIES

Zsolt Szijgyarto, Koen D. Flach, Mark Opdam, Carlo Palmieri, Sabine C. Linn, Jelle Wesseling, Simak Ali, Judith M. Bliss, Maggie Chon U. Cheang, Wilbert Zwart, R. Charles Coombes

28.01.2019 | Clinical trial | Ausgabe 1/2019

Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery

Maggie L. DiNome, Amy M. Kusske, Deanna J. Attai, Cheryce P. Fischer, Anne C. Hoyt

30.01.2019 | Clinical trial | Ausgabe 1/2019

The effects of psychosexual counseling on sexual quality of life and function in Iranian breast cancer survivors: a randomized controlled trial

Shakiba Fatehi, Raziyeh Maasoumi, Giti Atashsokhan, Azam Hamidzadeh, Ghasem Janbabaei, Seyed Mohammad Mirrezaie

31.01.2019 | Clinical trial | Ausgabe 1/2019

Factors influencing the use of extended adjuvant endocrine therapy

Kunal C. Kadakia, Kelley M. Kidwell, Debra L. Barton, Anne F. Schott, Daniel F. Hayes, Jennifer J. Griggs, N. Lynn Henry

02.02.2019 | Clinical trial | Ausgabe 1/2019

Efficacy of self-administered complex decongestive therapy on breast cancer-related lymphedema: a single-blind randomized controlled trial

M. B. Ligabue, I. Campanini, P. Veroni, A. Cepelli, M. Lusuardi, A. Merlo

04.02.2019 | Clinical trial | Ausgabe 1/2019

Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort

Jiwoong Jung, Wonshik Han, Eun Sook Lee, So-Youn Jung, Jai Hong Han, Dong-Young Noh, Yumi Kim, Hee Jun Choi, Jeong Eon Lee, Seok Jin Nam, Jong Won Lee, Hee Jeong Kim, Eunhae Um, Joo Heung Kim, Seho Park, Young Up Cho

06.02.2019 | Clinical trial | Ausgabe 1/2019

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

Ulrich Bick, Christoph Engel, Barbara Krug, Walter Heindel, Eva M. Fallenberg, Kerstin Rhiem, David Maintz, Michael Golatta, Dorothee Speiser, Dorothea Rjosk-Dendorfer, Irina Lämmer-Skarke, Frederic Dietzel, Karl Werner Fritz Schäfer, Elena Leinert, Stefanie Weigel, Stephanie Sauer, Stefanie Pertschy, Thomas Hofmockel, Anne Hagert-Winkler, Karin Kast, Anne Quante, Alfons Meindl, Marion Kiechle, Markus Loeffler, Rita K. Schmutzler, the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC)

21.01.2019 | Epidemiology | Ausgabe 1/2019

Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk

Anna Weiss, Samantha Grossmith, Danielle Cutts, Sage A. Mikami, Johanna A. Suskin, Mary Knust Graichen, Negui Arilis Rojas, Lydia E. Pace, Eileen Joyce, Esther Rhei, Rochelle Scheib, Brittany Bychkovsky, Judy E. Garber, Daniel Morganstern, Tari A. King

05.02.2019 | Epidemiology | Ausgabe 1/2019

Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction

Yasin Hussain, Esther Drill, Chau T. Dang, Jennifer E. Liu, Richard M. Steingart, Anthony F. Yu

06.02.2019 | Epidemiology | Ausgabe 1/2019

Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women

Tess O’Meara, Anton Safonov, David Casadevall, Tao Qing, Andrea Silber, Brigid Killelea, Christos Hatzis, Lajos Pusztai

01.02.2019 | Letter to the Editor | Ausgabe 1/2019

HER2 positive breast cancer patients having HER2 loss after neoadjuvant chemotherapy should still be treated with adjuvant anti-HER2 treatment

Kadri Altundag

05.02.2019 | Letter to the Editor | Ausgabe 1/2019

Change in study randomization allocation needs to be included in statistical analysis: comment on ‘Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study’

Stephanie L. Dickinson, Lilian Golzarri-Arroyo, Andrew W. Brown, Bryan McComb, Chanaka N. Kahathuduwa, David B. Allison

10.01.2019 | Correction | Ausgabe 1/2019 Open Access

Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

Ulrike Nitz, Oleg Gluz, Matthias Christgen, Ronald E. Kates, Michael Clemens, Wolfram Malter, Benno Nuding, Bahriye Aktas, Sherko Kuemmel, Toralf Reimer, Andrea Stefek, Fatemeh Lorenz-Salehi, Petra Krabisch, Marianne Just, Doris Augustin, Cornelia Liedtke, Calvin Chao, Steven Shak, Rachel Wuerstlein, Hans H. Kreipe, Nadia Harbeck

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.